Prevalence of anxiety and depression among patients with glaucoma

Front Psychol. 2024 Aug 22:15:1410890. doi: 10.3389/fpsyg.2024.1410890. eCollection 2024.

Abstract

Purpose: This study aimed to determine the prevalence of anxiety and depression among patients with glaucoma compared to the average Brazilian prevalence (9.8% of anxiety and 5.8% of depression, according to the World Health Organization) and its correlation with the severity of the disease.

Methods: This was a transversal, single-arm trial of patients from four glaucoma centers in São Paulo and Curitiba-Brazil. Patients comprised adults at least 18 years of age with glaucoma diagnosis under treatment for at least 6 months. All subjects of the study answered two questionnaires (PHQ-9 and GAD-7) to evaluate the presence of anxiety and depression, and the results were analyzed accordingly to clinical and demographic characteristics.

Results: The protocol included a total of 210 patients. The average age was 61.6 ± 15.3 years, and the female gender was more common (68.86%). Primary open-angle glaucoma was the most common diagnosis (59.90%). The average IOP was 18.5 mmHg, and 1.5 anti-glaucoma drops were the mean treatment. The prevalence of depression and anxiety was 26.90 and 25.71%, respectively. Most patients with anxiety were classified as early glaucoma, while those with depression had severe glaucoma.

Conclusion: This study found that the prevalence of anxiety and depression among patients with glaucoma is higher than in the general population in our country.

Keywords: GAD-7; PHQ-9; anxiety; depression; glaucoma.

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.